Risk factors
Tvardi Therapeutics (TVRD) risk factors
Item 1A of every Tvardi Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors83 risks77 new68 dropped6 reworded
Tvardi Therapeutics completed a reverse merger, shifting its risk profile entirely toward clinical development of TTI-101 and TTI-109.
Filed Mar 31, 2026 - FY2024 10-K risk factors74 risks
Tvardi Therapeutics is pursuing a reverse merger with Cara Therapeutics, involving significant ownership dilution and closing conditions.
Filed Mar 11, 2025